XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   73,317      
Beginning balance at Dec. 31, 2023 $ 538,085 $ 73 $ 942,280 $ 582 $ (404,850)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of new capped calls associated with the 2029 convertible senior notes (93,438)   (93,438)    
Partial termination of existing capped calls associated with the 2025 convertible senior notes 539   539    
Issuance of common stock upon exercise of stock options (in shares)   14      
Issuance of common stock upon exercise of stock options 386   386    
Issuance of common stock upon vesting of restricted stock units (in shares)   518      
Issuance of common stock upon vesting of restricted stock units 1 $ 1      
Stock-based compensation 45,987   45,987    
Other comprehensive loss (885)     (885)  
Net income (loss) (7,077)       (7,077)
Ending balance (in shares) at Mar. 31, 2024   73,849      
Ending balance at Mar. 31, 2024 483,598 $ 74 895,754 (303) (411,927)
Beginning balance (in shares) at Dec. 31, 2024   75,808      
Beginning balance at Dec. 31, 2024 622,192 $ 76 1,039,125 636 (417,645)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options 3   3    
Issuance of common stock upon vesting of restricted stock units (in shares)   435      
Issuance of common stock upon vesting of restricted stock units   $ 0      
Stock-based compensation 41,654   41,654    
Other comprehensive loss (139)     (139)  
Net income (loss) 576       576
Ending balance (in shares) at Mar. 31, 2025   76,243      
Ending balance at Mar. 31, 2025 $ 664,286 $ 76 $ 1,080,782 $ 497 $ (417,069)